MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2022 International Congress

    PD+: A comprehensive, user-friendly mobile application for clinicians treating Parkinson’s Disease

    E. Shah, T. Khachatryan, N. Phielipp, S. Isfahani (Orange, USA)

    Objective: We developed a mobile application that converts dopaminergic medication dosages and calculates total Levodopa (L-dopa) equivalent daily dose (LEDD) in a Parkinson’s Disease (PD)…
  • 2022 International Congress

    Manifestations of Parkinson’s Disease in different ethnicities in Sumatera Indonesia: A Descriptive Study

    S. Marisdina, S. Handayani, Y. Diansari, A. Afriani, R. Odiesta, M. Nur'Aini (Palembang, Indonesia)

    Objective: To describe manifestations of Parkinson’s Disease (PD) in different ethnicities in Sumatera, Indonesia. Background: Prevalence of PD is varied around the world. Some studies…
  • 2022 International Congress

    Effectiveness of a home-based exercise program on gait characteristics in an individual with Parkinson’s disease over a one-year period: A case study

    F. Khobkhun, P. Srivanitchapoom, J. Richards (Nakhon Pathom, Thailand)

    Objective: The purpose of this study was to explore the case history of an individual with Parkinson’s disease (PD) who used a home-based exercise programme…
  • 2022 International Congress

    Development and validation of clinical scales for defining RBD severity in participants of the North American Prodromal Synucleinopathy (NAPS) consortium

    A. Busicescu (Phoenix, USA)

    Objective: The objective of this study is to assess the internal validity of the REM Sleep Behavior Disorder (RBD) symptom severity scale (RBDSSS) and its…
  • 2022 International Congress

    Improving Dual Task Walking Control after Training with Internal-focus Strategy in Parkinson Disease with Freezing of Gait

    SH. Yu, CY. Huang, CH. Sheu, RM. Wu, YC. Liao (Taipei, Taiwan)

    Objective: To investigate the dual task walking training effects with different attentional focus strategies in patient with Parkinson’s Disease (PD) who had freezing of gait…
  • 2022 International Congress

    Retinal vascular change of Parkinson’s disease patients with orthostatic hypotension

    JH. Ahn, D. Lee, JW. Cho, KA. Park, J. Youn (Seoul, Republic of Korea)

    Objective: In the present study, we investigated difference of microvasculature of Parkinson’s disease (PD) patients with orthostatic hypotension (OH) and without OH, using optical coherence…
  • 2022 International Congress

    The relationship between sleep and Parkinson’s disease progression: A Mendelian Randomization study

    E. Matar, M. Mahjoub (Sydney, Australia)

    Objective: The objective of the study was to determine the causality between sleep disorders and progression of motor and cognitive endpoints of Parkinson’s disease. Background:…
  • 2022 International Congress

    Evaluation of Actigraphy-Based Circadian Rhythm and Motor Function Measures for Monitoring Treatment of Lewy Body Dementia in PRESENCE Study

    X. Dang, J. Wang, C. Battioui, M. Williamson, J. Zou, A. Hake, H. Zhang, B. Winger, J. Yang, K. Biglan (Cambridge, USA)

    Objective: To evaluate if wrist actigraphy data can derive clinically meaningful information reflecting circadian rhythm and motor functions from patients with Lewy body dementia (LBD)…
  • 2022 International Congress

    Parkinsonian disorders may have different pain features.

    SY. Kang, YH. Sung (Hwaseong, Republic of Korea)

    Objective: The aim of this study was whether the pain is a unique feature of Parkinson's disease, which precedes motor symptoms, and its characteristics would…
  • 2022 International Congress

    Descriptive case studies of patients in their fifth consecutive year of treatment with ND0612

    A. Espay, A. Ellenbogen, T. Gurevich, R. Case, L. Adar, T. Yardeni, L. Salin (Cincinnati, USA)

    Objective: To describe the long-term experience of three individual patients receiving subcutaneous (SC) levodopa/carbidopa infusion with ND0612 in an open-label clinical safety study. Background: ND0612…
  • « Previous Page
  • 1
  • …
  • 606
  • 607
  • 608
  • 609
  • 610
  • …
  • 1734
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley